Marshall Wade Cunningham, MD | |
1020 S State Highway 16, Fredericksburg, TX 78624-4471 | |
(830) 997-4353 | |
(830) 990-1599 |
Full Name | Marshall Wade Cunningham |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 1020 S State Highway 16, Fredericksburg, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770566861 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | L9037 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Marshall Wade Cunningham, MD Po Box 294145, Kerrville, TX 78029-4145 Ph: (888) 779-3675 | Marshall Wade Cunningham, MD 1020 S State Highway 16, Fredericksburg, TX 78624-4471 Ph: (830) 997-4353 |
News Archive
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, today announced its support of more than 150 rapid HIV testing initiatives taking place in more than 25 states in the U.S. and numerous countries globally, in recognition of World AIDS Day, commemorated annually on December 1st.
Breast augmentation is the most frequent type of plastic surgery done in the UK and - after nose reshaping and liposuction - it is the third most common cosmetic procedure in the USA.
In Drosophila, like in humans, male cells have a single X chromosome, while female cells have two. Researchers have long debated over how X and autosomal chromosome gene expression is equalized between the sexes (generally regarding two different models, known as the activation model and the inverse model).
Forest Laboratories, Inc. announced today that the U.S. Food and Drug Administration did not approve the additional indication for Bystolic® (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the company's Supplemental New Drug Application (sNDA).
Teva Pharmaceutical Industries Limited announced today that it successfully priced its debut EUR 1 billion and CHF 450 million debt offerings, and that it entered into a JPY 100 billion senior unsecured fixed-rate syndicated term loan facility.
› Verified 6 days ago